JBA
LLY icon

Johnson Bixby & Associates’s Eli Lilly LLY Stock Holding History

Johnson Bixby & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
341
+11
+3% +$11.2K 0.05% 89
2026
Q1 		$304K Buy
+330
New +$335K 0.04% 100

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Johnson Bixby & Associates's LLY Position: Q2 2026 in Review

Johnson Bixby & Associates increased its Eli Lilly (LLY) stake by 3.3% in Q2 2026, buying an estimated $11.2K and bringing the position to 341 shares worth $409K. The position accounts for 0.05% of the portfolio, ranked #89.

Johnson Bixby & Associates first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Johnson Bixby & Associates held 341 shares of Eli Lilly worth $409K as of Q2 2026.
  • Johnson Bixby & Associates bought 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
  • Eli Lilly made up 0.05% of Johnson Bixby & Associates's portfolio in Q2 2026, its #89 holding.
  • Johnson Bixby & Associates first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Johnson Bixby & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.